9.61
Skye Bioscience, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
8.94
FY23:
11.7
FY24:
70.8
FY25:
27.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.24
FY22:
0.17
FY23:
0.29
FY24:
1.94
FY25:
1.22
Total assets
Change from FY21 to FY25
millions USD
FY21:
9.86
FY22:
9.11
FY23:
11.9
FY24:
72.8
FY25:
28.3
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
3.91
FY22:
12.1
FY23:
13.9
FY24:
4.34
FY25:
8.21
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.08
FY22:
0
FY23:
0.17
FY24:
0.27
FY25:
0.08
(positive)
Change from FY21 to FY25
millions USD
FY21:
5.86
FY22:
−3.01
FY23:
−2.13
FY24:
68.2
FY25:
20.0
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
9.86
FY22:
9.11
FY23:
11.9
FY24:
72.8
FY25:
28.3
All amounts in millions USD